On January 23, 2023, DarioHealth Corp. (the Company), through its wholly owned subsidiary Labstyle Innovation Ltd., executed a Termination of Employment and Separation Agreement (the Agreement) with Dror Bacher, the Company's Chief Operating Officer, pursuant to which Mr. Bacher's position as Chief Operating Officer was terminated with immediate effect. Pursuant to the terms of the Agreement, the Company agreed to retain Mr. Bacher as a member of its advisory board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.18 USD | +0.85% | -1.67% | -31.40% |
Jun. 05 | DarioHealth Appoints Steven Nelson as Chief Commercial Officer | MT |
Jun. 05 | DarioHealth Corp. Announces Management Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.40% | 35.01M | |
-6.24% | 180B | |
-6.08% | 98.89B | |
-5.98% | 66.26B | |
-9.35% | 44.61B | |
+8.34% | 44.02B | |
+10.24% | 40.12B | |
+11.88% | 29.19B | |
-8.38% | 23.64B | |
+15.38% | 23.41B |
- Stock Market
- Equities
- DRIO Stock
- News DarioHealth Corp.
- DarioHealth Corp. Announces Termination of Dror Bacher, Chief Operating Officer